SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman reminds investors that the deadline to move the Court for appointment as lead plaintiff in the securities class action lawsuit against Telix Pharmaceuticals Ltd. (NASDAQ: TLX) is January 9, 2026. The lawsuit follows a series of regulatory setbacks and steep stock declines, including a 21% drop after the final regulatory news. The complaint alleges that Telix and its executives materially overstated the develo ...